FindTrial
Sign In

Surgicel® (Fibrillar) in Non-variceal UGI Bleeding

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02054260
Enrollment
Unknown
Registered
2014-02-04
Start date
Unknown
Completion date
Unknown
Last updated
2014-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-variceal Upper Gastrointestinal Bleeding

Brief summary

The aim of this study is to assess of effect of Surgicel® (Fibrillar) for preventing delayed bleeding after endoscopic hemostasis in non-variceal upper gastrointestinal bleeding

Interventions

DRUGSurgicel

Sponsors

Soonchunhyang University Hospital
Lead SponsorOTHER

Eligibility

Sex/Gender
ALL
Age
20 Years to 75 Years

Inclusion criteria

* Patients with non variceal upper gastrointestinal bleeding proven by esophagogastroduodenoscopy * Patients with active bleeding (Forrest classification Ia or Ib or IIa)

Exclusion criteria

* Patients with upper gastrointestinal tract malignancy * Patients with acute severe illness * Coagulopathy: liver cirrhosis, thrombocytopenia * Pregnant women

Design outcomes

Primary

MeasureTime frame
Rebleeding rate at the second look endoscopy2 year

Countries

South Korea

Contacts

Primary ContactSu Jin Hong, MD, PhD
sjhong@schmc.ac.kr+82-32-621-5087

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026